Latest Blogs

May 24, 2018
In the midst of troubles in North Africa and Middle East, we keep up with oncology education and research and keep up hope for the betterment of patient care and advancement of science in Arab countries. 
May 24, 2018
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
May 24, 2018
As the NSABP celebrates its 60th anniversary in 2018, Dr. Harry D. Bear honors the organization's history and accomplishments.
May 23, 2018
IDEA and LIFe recipient Dr. Susmita Sharma is working hard during her U.S. fellowship so that she can achieve her dream of delivering exceptional cancer care to her patients in Nepal. 
Subscribe to this column

Bruce E. Johnson, MD, FASCO

Bruce E. Johnson, MD, FASCO, is the 2017-2018 ASCO President. He is chief clinical research officer and institute physician at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School. He is the director of the Dana-Farber/Harvard Cancer Center (DF/HCC) Lung Cancer Program. He served as director of the Lowe Center for Thoracic Oncology from 1998 through 2013.
 
An ASCO member since 1985, Dr. Johnson has served in numerous volunteer and leadership roles, including the Board of Directors (2008-2011), Chair of the Audit, Cancer Education, and Cancer Communications Committees, and on the Journal of Clinical Oncology Editorial Board, among other positions. In 2008, he was awarded the Translational Research Professorship from the Conquer Cancer Foundation of ASCO; in 2012, he was elected as a Fellow of ASCO (FASCO).

May 21, 2018
Take the survey today and help shape the future of cancer care.
May 18, 2018
As the ASCO Annual Meeting approaches, I discuss the theme that I selected for the meeting and for my presidential term.
May 14, 2018
Our Annual Meeting features the brightest minds of oncology, and provides a matchless opportunity to network with our colleagues from the United States and around the world. 
Dec 21, 2017
ASCO urges Congress to protect Medicare beneficiaries with cancer and other medical conditions by passing additional legislation to avoid cuts to the program.
Dec 01, 2017
We are committed to supporting and promoting practical policy solutions that ensure patients with cancer have access to, and can afford, drugs vital to their treatment.
Jul 11, 2017
The price of and access to oncology drugs remains both a national and international challenge to our patients, providers, and third-party payers.

Pages